News

Vir Biotechnology: Tobevibart Combination Pushing Forward For Needed HDV Treatment
Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...
Yahoo Finance2d
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
SAN FRANCISCO, May 12, 2025--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside ...